- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 177
Diabeloop ties together $24m series B
Diabetes management system developer Diabeloop will use the funding from the Agir à dom and Air Liquide-backed round to accelerate growth.
Dec 3, 2019Corporate venturing deal net: 25-29 November 2019
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Nov 29, 2019Jybd hauls in $50m
A subsidiary of Sino-Ocean Group has led a $50m series B round for Manbang-backed aftermarket automotive services provider Jybd.
Nov 29, 2019Jinlong picks Clover in $43m series B
Cancer and autoimmune disease drug developer Clover Biopharmaceuticals has now raised in excess of $100m altogether, Jinrong Group backing its latest round.
Nov 29, 2019RT-Thread rotates to series B stage
Returning investor Legend Capital contributed to a $14.2m round for the IoT operating system developer that will fund research and development.
Nov 29, 2019Line helps Amartha draw up $18m round
Line Ventures led an $18m round for the female-focused microlending marketplace that included fellow corporate VC vehicle UOB Venture Management.
Nov 29, 2019Cymulate reaches series B cycle with $15m
Existing investors Dell Technologies Capital and SGE returned to help boost simulation-based cybersecurity software platform Cymulate's total funding to $26m.
Nov 28, 2019Loom loots $30m in series B round
The Slack-backed enterprise video messaging platform took its total funding to $45m with a Sequoia-led round that will fund product development.
Nov 27, 2019NetEase tosses funding to Bossa
NetEase has led a series B round for the game developer reportedly sized at up to $30m and will now help it expand into China.
Nov 27, 2019Heartseed to grow with series B funding
JMDC, Gene Techno Science, Astellas Venture Management and Nissay Capital have contributed to a $25.8m round for Keio University's heart failure treatment developer.
Nov 26, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


